29
Jun
2020
Blog
News & Views
Search
22
Jun
2020
Bionest
ASCO 2020: Part 1
In our first of two ASCO 2020 posts, we discuss clinical data from an off-the-shelf CAR-T therapy, and look at how real-world evidence can be used to help physicians improve outcomes for their cancer patients in ways beyond cancer treatment itself.
8
Jun
2020
Bionest
Funding Environment During COVID-19 Pandemic Sees Both Challenges and Bright Spots
While some pharma and biotech companies are struggling during the COVID-19 pandemic, others are thriving thanks to government grants, joint research initiatives and venture capital.
1
Jun
2020
Bionest
Coronavirus Impacts on Industry: Part 2
The COVID-19 pandemic is causing a slow-down in clinical trials, manufacturing, and other industry activities.
25
May
2020
Bionest
Coronavirus Impacts on Industry: Part 1
As the COVID-19 pandemic rages on, the effects of the virus are being felt not only by the global populace, but by the various sectors of the health care industry and those that support them.
18
May
2020
Bionest
Coronavirus Impacts on Patient Care: Part 2
Physicians, health systems, and medical groups are embracing virtual health care at a level not seen prior to COVID-19.
11
May
2020
Bionest
Coronavirus Impacts on Patient Care: Part 1
The rapid spread of COVID-19 is having significant effects on patient care overall, including for illnesses and conditions unrelated to the virus.
27
Apr
2020
Bionest
Actions Around Drug Pricing Centering on Insulin
An increasing number of diabetes patients face affordability challenges for their insulin. How are pharma companies and the government responding?
13
Apr
2020
Bionest
FDA Finalizes Gene Therapy Guidelines and Adds New Draft Guidance on Orphan Drug Exclusivity
The field of gene and cell therapy is flourishing. How is the FDA responding?
30
Mar
2020